HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients

被引：0
|
作者：
Jiezuan Yang
Jiajia Chen
Ping Ye
Linfeng Jin
Wei Wu
Guoping Sheng
Lan-Juan Li
机构：
[1] the First Affiliated Hospital,State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
[2] College of Medicine,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases
[3] Zhejiang University,undefined
[4] Zhejiang University,undefined
来源：
Journal of Translational Medicine | / 12卷
关键词：
Chronic hepatitis B; Antiviral treatment; HBsAg quantitation; HBeAg seroconversion; Prognostic indicator;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients
    Yang, Jiezuan
    Chen, Jiajia
    Ye, Ping
    Jin, Linfeng
    Wu, Wei
    Sheng, Guoping
    Li, Lan-Juan
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [2] HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
    Guangjun Song
    Ruifeng Yang
    Qian Jin
    Juan Liu
    Huiying Rao
    Bo Feng
    Yandi Xie
    [J]. BMC Gastroenterology, 23
  • [3] HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
    Song, Guangjun
    Yang, Ruifeng
    Jin, Qian
    Liu, Juan
    Rao, Huiying
    Feng, Bo
    Xie, Yandi
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [4] PREDICTION OF HBsAg KINETICS AND HBEAG LOSS DURING ANTIVIRAL THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B
    Kim, Hwi Young
    Jang, Tae Soo
    Lee, Joo Ho
    Lee, Hye Ah
    Kwon, Hee-Dae
    [J]. HEPATOLOGY, 2020, 72 : 518A - 518A
  • [5] Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment
    Zhao, Xiang-An
    Wang, Jian
    Liu, Jiacheng
    Chen, Guangmei
    Yan, Xiaomin
    Jia, Bei
    Yang, Yue
    Liu, Yong
    Gu, Da
    Zhang, Zhaoping
    Xiang, Xiaoxing
    Huang, Rui
    Wu, Chao
    [J]. ANTIVIRAL RESEARCH, 2021, 193
  • [6] Predictive Factors for Early HBeAg Seroconversion in Acute Exacerbation of Patients With HBeAg-Positive Chronic Hepatitis B
    Kim, Hyoung Su
    Kim, Ha Jung
    Shin, Woon Geon
    Kim, Kyung Ho
    Lee, Jin Heon
    Kim, Hak Yang
    Jang, Myoung Kuk
    [J]. GASTROENTEROLOGY, 2009, 136 (02) : 505 - 512
  • [7] Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B
    Pfefferkorn, Maria
    Schott, Tina
    Boehm, Stephan
    Deichsel, Danilo
    Felkel, Christin
    Gerlich, Wolfram H.
    Glebe, Dieter
    Wat, Cynthia
    Pavlovic, Vedran
    Heyne, Renate
    Berg, Thomas
    van Boemmel, Florian
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (02) : 283 - 292
  • [8] IMPROVED HBeAg SEROCONVERSION BY SEQUENTIAL TELBIVUDINE THERAPY FOLLOWING PARTIAL RESPONSE TO PEGYLATED INTERFERON TREATMENT IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Zheng, Q.
    Zhu, Y. Y.
    Chen, J.
    Liu, R. Y.
    Dong, J.
    Zeng, W. D.
    Jiang, J. J.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S432 - S432
  • [9] Prediction of Spontaneous HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients During the Immune Clearance Phase
    Song, Guangjun
    Rao, Huiying
    Feng, Bo
    Wei, Lai
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (11) : 1838 - 1844
  • [10] The predictive value of early indicators for HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with Telbivudine treatment for 104 weeks
    Wang, Juan
    Du, Ling-yao
    Zhu, Xia
    Chen, En-qiang
    Tang, Hong
    [J]. INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 33 : S20 - S25
12345